ASX - By Stock
|
BRK |
Re:
Proposed Executive Share Issue
|
|
thomb2
|
50 |
9.6K |
9 |
11:54 |
11:54 |
ASX - By Stock
|
50
|
9.6K
|
9
|
|
ASX - By Stock
|
ARX |
Re:
Ann: March 2024 Quarterly Report and Appendix 4C
|
|
thomb2
|
8 |
1.5K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
8
|
1.5K
|
1
|
|
ASX - By Stock
|
BRK |
Re:
Ann: FMDP Drilling Update
|
|
thomb2
|
13 |
3.9K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
13
|
3.9K
|
0
|
|
ASX - By Stock
|
BRK |
Re:
Ann: SWISH Full Field Development to Grow Output & Net Income
|
|
thomb2
|
48 |
15K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
48
|
15K
|
4
|
|
ASX - By Stock
|
LGP |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
thomb2
|
9 |
3.1K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
3.1K
|
3
|
|
ASX - By Stock
|
LGP |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
thomb2
|
9 |
3.1K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9
|
3.1K
|
1
|
|
ASX - By Stock
|
CYL |
Re:
Ann: Quarterly activities report
|
|
thomb2
|
25 |
9.4K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
25
|
9.4K
|
2
|
|
ASX - By Stock
|
BRK |
Re:
Ann: SWISH Full Field Development to Grow Output & Net Income
|
|
thomb2
|
48 |
15K |
6 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
48
|
15K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
thomb2
|
369 |
127K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
127K
|
3
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Aroa Biosurgery Half Yearly Results H1 FY24
|
|
thomb2
|
5 |
2.8K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
5
|
2.8K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Ann: FY23 Full Year Results Presentation
|
|
thomb2
|
15 |
6.7K |
2 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
15
|
6.7K
|
2
|
|
ASX - By Stock
|
ARX |
Re:
Ann: FY23 Full Year Results Presentation
|
|
thomb2
|
15 |
6.7K |
1 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
15
|
6.7K
|
1
|
|
ASX - By Stock
|
LGP |
Re:
2023 for LGP
|
|
thomb2
|
30 |
21K |
0 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
30
|
21K
|
0
|
|
ASX - By Stock
|
PLL |
Re:
Ann: Piedmont & LG Chem Sign Equity Investment & Binding Offtake
|
|
thomb2
|
35 |
11K |
0 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
35
|
11K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
chart
|
|
thomb2
|
7 |
3.9K |
0 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
7
|
3.9K
|
0
|
|
ASX - By Stock
|
WHC |
Re:
Ann: Dividend/Distribution - WHC
|
|
thomb2
|
61 |
25K |
12 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
61
|
25K
|
12
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Change of Director's Interest Notice - Mr Richard Valencia
|
|
thomb2
|
2 |
859 |
2 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
2
|
859
|
2
|
|
ASX - By Stock
|
NCZ |
Re:
Reports/Decisions due by 9January
|
|
thomb2
|
28 |
12K |
0 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
28
|
12K
|
0
|
|
ASX - By Stock
|
NCZ |
Re:
March quarter predictions
|
|
thomb2
|
49 |
23K |
3 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
49
|
23K
|
3
|
|
ASX - By Stock
|
NCZ |
Re:
Reports/Decisions due by 9January
|
|
thomb2
|
28 |
12K |
1 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
28
|
12K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
Another Positive Study
|
|
thomb2
|
154 |
82K |
1 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
154
|
82K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
Another Positive Study
|
|
thomb2
|
154 |
82K |
3 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
154
|
82K
|
3
|
|
ASX - By Stock
|
PLL |
Re:
Ann: Piedmont Lithium Expands Board of Directors
|
|
thomb2
|
5 |
2.2K |
2 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
5
|
2.2K
|
2
|
|
ASX - By Stock
|
5EA |
Re:
A (NASDAQ) Valuation of FEAM
|
|
thomb2
|
11 |
6.3K |
0 |
01/01/23 |
01/01/23 |
ASX - By Stock
|
11
|
6.3K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Reports Third Quarter 2022 Financial Results
|
|
thomb2
|
79 |
35K |
3 |
31/12/22 |
31/12/22 |
ASX - By Stock
|
79
|
35K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Reports Third Quarter 2022 Financial Results
|
|
thomb2
|
79 |
35K |
10 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
79
|
35K
|
10
|
|
ASX - By Stock
|
TIE |
Re:
General comment
|
|
thomb2
|
177 |
50K |
0 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
177
|
50K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Another Positive Study
|
|
thomb2
|
154 |
82K |
1 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
154
|
82K
|
1
|
|
ASX - By Stock
|
MME |
Re:
Ann: AGM Scripts and Presentation Slides
|
|
thomb2
|
47 |
15K |
2 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
47
|
15K
|
2
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Notification regarding unquoted securities - ARX
|
|
thomb2
|
2 |
879 |
0 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
2
|
879
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
thomb2
|
194 |
86K |
6 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
194
|
86K
|
6
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
0 |
23/11/22 |
23/11/22 |
Charts
|
458
|
289K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
0 |
18/11/22 |
18/11/22 |
Charts
|
458
|
289K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Ann: ImpediMed Reaches Milestone of 500,000 SOZO Patient Tests
|
|
thomb2
|
16 |
7.5K |
1 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
16
|
7.5K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Statement of CDIs on issue - AVH
|
|
thomb2
|
7 |
2.2K |
1 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
7
|
2.2K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Amazing ReCELL videos
|
|
thomb2
|
30 |
8.5K |
2 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
30
|
8.5K
|
2
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
1 |
06/10/22 |
06/10/22 |
Charts
|
458
|
289K
|
1
|
|
ASX - By Stock
|
MME |
Re:
Ann: Revised FY22 Annual Report Note 11
|
|
thomb2
|
8 |
4.1K |
1 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
8
|
4.1K
|
1
|
|
ASX - By Stock
|
MME |
Re:
Ann: Investor Presentation - FY22 Results and Capital Raise
|
|
thomb2
|
84 |
32K |
2 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
84
|
32K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Biotech comparison using Numbers
|
|
thomb2
|
28 |
10K |
5 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
28
|
10K
|
5
|
|
ASX - By Stock
|
TIE |
Re:
full steam ahead
|
|
thomb2
|
88 |
32K |
1 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
88
|
32K
|
1
|
|
ASX - By Stock
|
DDH |
Re:
Ann: Release of Securities from Voluntary Escrow
|
|
thomb2
|
3 |
1.1K |
0 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
3 |
27/08/22 |
27/08/22 |
Charts
|
458
|
289K
|
3
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
1 |
27/08/22 |
27/08/22 |
Charts
|
458
|
289K
|
1
|
|
ASX - By Stock
|
DDH |
Re:
Ann: DDH1 Notice of FY22 Results Conference Call Details
|
|
thomb2
|
4 |
1.4K |
0 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
4
|
1.4K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
0 |
19/08/22 |
19/08/22 |
Charts
|
458
|
289K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
0 |
19/08/22 |
19/08/22 |
Charts
|
458
|
289K
|
0
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
1 |
19/08/22 |
19/08/22 |
Charts
|
458
|
289K
|
1
|
|
Charts
|
ARX Biotech |
Re:
Come on finish 1.60 plus
|
|
thomb2
|
458 |
289K |
2 |
18/08/22 |
18/08/22 |
Charts
|
458
|
289K
|
2
|
|
ASX - By Stock
|
DDH |
Re:
Ann: Update - Notification of buy-back - DDH
|
|
thomb2
|
9 |
2.8K |
0 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
9
|
2.8K
|
0
|
|